Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims database
The Korean Journal of Internal Medicine. 2018;33(1):228-229 
PMS83 Adherence and Uric Acid Goal Attainment with Urate Lowering Therapy in Patients with Gout
Value in Health. 2012;15(4):A49
Effect of Fenofibrate in Combination with Urate Lowering Agents in Patients with Gout
The Korean Journal of Internal Medicine. 2006;21(2):89
Long-Term Decrease In Gout Flare Rates Associated With Effective Urate Lowering Therapy
Value in Health. 2015;18(3):A155
Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
BMC Musculoskeletal Disorders. 2012;13(1):
Treatment approaches and adherence to urate-lowering therapy for patients with gout
Patient Preference and Adherence. 2017;Volume 11:795-800
Intensive urate-lowering therapy improves structural joint damage in patients with tophaceous gout
Nature Reviews Rheumatology. 2013;9(9):506-506
Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout
Current Rheumatology Reports. 2018;20(8):
Significance of the initiation time of urate-lowering therapy in gout patients: A retrospective research
Joint Bone Spine. 2015;82(6):428-431
Inpatient rheumatology consultation for gout flares and advice to initiate urate lowering treatment (ULT) in hospital discharge summary increases ULT prescription in primary care
Joint Bone Spine. 2018;